Search

The article focuses on the importance of maintaining the openness of the U.S. research ecosystem while addressing threats posed by foreign influences, particularly from the People's Republic of China. Topics include disclosure requirements for federal R&D funding applicants, policies regarding participation in foreign talent recruitment programs, and efforts to enhance research security training and program requirements.

The article focuses on the Advanced Research Projects Agency for Health (ARPA-H), a new agency proposed by the Biden Administration to advance biomedical and health research. It discusses the establishment and structure of ARPA-H, highlighting its similarities to other ARPA agencies and its potential to fund high-risk, high-reward research defining its role in the biomedical research ecosystem, facilitating the implementation of ARPA-H innovations, and determining adequate funding levels.

The article presents a report from the U.S. Congressional Research Service on science and technology issues for the 118th U.S. Congress Topics discussed include interagency coordination; workforce adequacy; intellectual property policies; and tax incentives. Other areas of focus include agriculture, climate change, biotechnology, defense, energy, earth and environmental sciences.

The article focuses on the U.S. Congress has increased support for economic development policies that incorporate a regional innovation systems (RIS) approach. It mentions RIS approach seeks to develop an ecosystem that fosters linkages between organizations so that a region may increase jobs attract investment. It also mentions federal support for RIS and restructure places and regional economies that have been impacted by globalization and international trade.

The article provides an overview of scientific integrity and selected issues for congressional consideration in the U.S. It mentions scientific integrity policies include principles of research integrity in the conduct of science by federal scientists, open and trustworthy supervision and communication of federal science, and the appropriate use of science in policy development and decision-making.

The article provides an overview of the executive order 14081 "Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy" issued by the U.S. President Joe Biden. It offers details supporting federal investments announced by the Administration, and offers some policy considerations for Congress regarding implementation of the executive order.

The article discusses bioeconomy and how it can be used to address major challenges like climate change, food security, environmental sustainability and energy independence by citing the situation in the U.S. Also cited are bioeconomy as a share of the economy based on services, products, and processes obtained from biological resources like microorganisms and plants, and the Office of Science and Technology Policy's (OSTP) vision for the bioeconomy.

The article discusses the U.S. Congressional Research Service report which provides an overview of Advanced Research Projects Agency for Health (ARPA-H) as proposed by the President Joe Biden Administration. It discusses selected policy issues still under debate as Congress considers legislation that would explicitly authorize ARPA-H.

The article provides information on mRNA and mRNA technologies. It discusses potential future uses of mRNA-based medicine including mRNA-based vaccines, cancer treatments and rare disease treatment, as well as federal support, market projections and private investments related to mRNA technologies. It identifies potential considerations for the U.S. Congress including role of the federal government in mRNA research and development and coordination of federal research.

The article reports that the U.S. Congress provided to the Department of Health and Human Services (HHS) to establish the Advanced Research Projects Agency for Health (ARPA-H). It mentions HHS Secretary Xavier Becerra submitted a notice to the appropriations committees that ARPA-H is to reside within the National Institutes of Health (NIH). It also mentions need to drive transformational health research innovation and speed medical breakthroughs.

The article examines the budget request of U.S. President Joseph Biden for federal research and development (R&D) funding for fiscal year 2022. The government support for scientific and engineering R&D focused on national defense, health, safety, environment and energy security. Majority of the R&D funding involved the Department of Defense and Department of Health and Human Services. Also emphasized is the role of Congress in defining the R&D priorities of the U.S.

The article discusses the U.S. Congressional Research Service report which provides an overview of the Small Business Innovation Research (SBIR) program, and Small Business Technology Transfer (STTR) program. It mentions that SBIR program was established in 1982 by the Small Business Innovation Development Act, and STTR was created by the Small Business Research and Development Enhancement Act of 1992 focusing on research and development efforts.

The article presents a report by the U.S. Congressional Research Service which describes global research and development landscape and implications for the Department of Defense. It mentions about increasing Department of Defense collaboration and engagement with industry and academia by driving the development of key technologies, and create a more agile and innovative department. It also informs on the take of Congress in addressing technical superiority.

The article presents a report of the U.S. Congressional Research Service, that discusses results of research and development (R&D) help inform the decisions that policymakers and the public reach on a wide range of issues, including human health and safety, the environment, agriculture, energy, and transportation. It mentions about a broad agreement among policymakers and the scientific community about ensuring the integrity of the conduct, and management of R&D.

The article focuses on Under Secretary of Defense for Research and Engineering (USD (R&E)) is a civilian official reporting directly to Secretary of Defense of the U.S. It mentions USD (R&E) serves as principal advisor to the Secretary of Defense for Department of Defense (DOD) research, engineering, and technology development activities and programs. It also mentions establishing policies on, and supervising all defense research, technology development and appropriate prototyping activities.

The article offers information on the Federal Research and Development (R&D) Funding by U.S. President Donald Trump for the fiscal 2021. It mentions Office of Management and Budget (OMB) adopted a change to the definition of development, applying a more narrow treatment that it describes as "experimental development." It also mentions Congress passed the Continuing Appropriations Act, 2021 and Other Extensions Act.

The article focuses on guidance of a 2010 memorandum issued by the Office of Science and Technology Policy, more than 20 federal departments and agencies have developed and implemented scientific integrity policies. It mentions Centers for Disease Control and Prevention (CDC) related to the COVID-19 pandemic that was inconsistent with political objectives. It also mentions alleged violations, interagency coordination of scientific integrity policies.

The report discusses of the overall level of Research and Development in the U.S. President Donald Trump's fiscal year 2021 budget request. Topics include business provides the vast majority of U.S. funding for development, and U.S. Department of Health and Human Services (HHS) would be the largest federal funder of applied research.

The article presents a summary of Senate Bill 2657 which is American Energy Innovation Act which reflects on federal role in energy policy and particularly related to research and development (R&D). It mentions energy issues addressed in the bill included research and development of renewable and nuclear energy technologies, carbon capture, utilization, and storage (CCUS); and promotions of small-scale liquefied natural gas (LNG) exports.

The article presents a reports of the U.S. Congressional Research Service, related to the U.S. Federal Research and Development (R&D) funding proposed by U.S. President Donald Trump in his budget. It mentions that several federal agencies received federal R&D funding including the U.S. Dept. of Defense and the U.S. Dept. of Health and Human Services.

The article focuses on the use of prize competitions by the federal government has increased since the passage of the America COMPETES Reauthorization Act of 2010. It mentions that federal agencies have increased the use of prize competitions to spur innovation and advance the mission of their respective agencies; and also mentions that in the 116th Congress more than 30 bills have been introduced to authorize or establish prize competitions within various federal agencies.

The article provides information on the U.S. federal government's research and development (R&D) funding for fiscal year (FY) 2020. President Donald Trump's budget request for this fiscal year consisted of nearly one hundred and thirty four billion dollars for R&D. Agencies with the biggest suggested cuts in R&D funding in the FY2020 budget compared to FY2018 actual levels included U.S. Department of Energy, National Science Foundation, and National Aeronautics and Space Administration.

The article presents an overview of the purpose, governance structure and federal funding associated with selected agency-related nonprofit research foundations and corporations in the U.S. The foundations include the Foundation for the National Institutes of Health (FNIH), National Foundation for the Centers for Disease Control and Prevention, Reagan-Udall Foundation for the Food and Drug Administration, and Foundation for Food and Agriculture Research (FFAR).

The article offers insight to the U.S. President Donald Trump's research and development budget request for Fiscal Year 2020. It mentions about appropriations status for Department of Defense, Department of Health and Human Services, and Department of Energy, and National Aeronautics and Space Administration.

The article offers information on the Federal Research and Development (R&D) Funding for fiscal year (FY) 2020 as of August 13, 2019. It further mentions U.S. President Donald Trump's budget request; the U.S. Global Change Research Program; and the National Aeronautics and Space Administration and National Institute of Food and Agriculture. Also mentions about the U.S. Environmental Protection Agency Science and Technology.

The article discusses the funding for Federal Research and Development (R&D) for the financial year FY) 2020 in U.S. It states 2020 budget included FY 2018 actual funding, 2019 annualized continuing resolution (CR), and FY 2020 request funds aiming to have science breakthroughs, innovation, and global competitiveness. It mentions government supports and funds several R & D sectors including defense, health, environment, agriculture and provides a list of funding chart sector wise.

The article offers a report CRISPR-Cas9, a gene editing technology that has a potential to revolutionize genetic engineering and the biotechnology industry. An overview of CRISPR-Cas9, along with its market projections, investments and research and development spending, is given. It provides information on the possible economic benefits of the technology, identifies issues for congressional consideration, and ethical and societal issues on the use of the technology.

The article focuses on Under Secretary of Defense for Research and Engineering (USD (R&E)) of the U.S. Department of Defense (DOD). It mentions USD (R&E) intended to promote faster innovation and to increase risk-tolerance in the pursuit of new technologies and identifying potential opportunities that warrant action and merit investment. It also mentions effective delivery of advanced technologies to the warfighter and effective leadership and management.

The article focuses on Under Secretary of Defense for Research and Engineering (USD (R&E)) is a civilian official reporting directly to the Secretary of Defense under the Department of Defense (DOD). It mentions powers and duties of the USD (R&E) include serving as the chief technology officer (CTO) of DOD; establishing policies on, and supervising all defense research and engineering and serving as the principal advisor to the Secretary of Defense on all research, engineering, and technology.

The article discusses the roles and responsibilities of the U.S. Under Secretary of Defense for Research and Engineering (USD (R&E)). Topics include the role of USD R&E as advisor to the Secretary of Defense for U.S. Department of Defense (DOD)'s research, engineering, and technology development programs; and its duties as the chief technology officer of DOD for advancing technology and innovation for the military services.

The article outlines the U.S. government policies and authorities concerning federal prize competitions as of mid-summer 2018, including the use of such competitions by U.S. government agencies and legislation concerning prize competitions during the 115th Congress.

The article discusses the federal funding of federally funded research and development centers (FFRDCs).

The federal government supports research and development (R&D) that is conducted by a wide variety of performers, including federally owned and operated laboratories, universities, private companies, and other research institutions. A special class of research institutions referred to as federally funded research and development centers, or FFRDCs, are owned by the federal government, but operated by contractors, including universities, other non-profit organizations, and industrial firms. FFRDCs are intended to provide federal agencies with R&D capabilities that cannot be effectively met by the federal government or the private sector alone. FFRDCs are required to have a long-term strategic relationship with the federal agency that supports them. This relationship is presumed to convey a number of benefits, including the ability of an FFRDC to recruit and retain scientific and technical expertise; an in-depth knowledge of, and the capability to rapidly respond to, the R&D needs of the federal agency; and the capacity to offer independent and objective scientific and technical advice. Currently, 12 federal agencies sponsor a total of 42 FFRDCs. These FFRDCs provide R&D capabilities in support of federal agency missions in a broad range of areas--from energy and cybersecurity to cancer and astronomy. In FY2015, the federal government obligated $11.1 billion or 8.6% of its total R&D spending to FFRDCs. Congress maintains a continuing interest in FFRDCs due to their contributions to U.S. technological and economic leadership. However, some Members of Congress have questioned the appropriate role of FFRDCs in the federal R&D enterprise and the ability of FFRDCs to effectively address federal agency R&D needs. The following issues have been of particular interest: (1) the effectiveness of federal agency oversight and management of FFRDCs; (2) competition between FFRDCs and the private sector for federal R&D funding; (3) the diversification of FFDRC activities or "mission creep"; and (4) the award of noncompetitive FFRDC management and operation contracts. [ABSTRACT FROM AUTHOR]

The article presents a U.S. Congressional Research Service report on gene editing technology known as CRISPR-Cas9. Topics covered include the coordinated framework for the regulation of biotechnology, application areas and issues for consideration such as human health and medicine, and potential regulatory implications for CRISPR-Cas9 in agriculture biotechnology.

An appendix is presented of list of federally funded research and development centers,for 2017, which include Arroyo Center, Lincoln Laboratory and Lawrence Livermore National Laboratory.

The article discusses how federally funded research and development centers (FFRDCs) contracts are competed for.

The article discusses the characteristics of federally funded research and development centers (FFRDCs).

The article reports that at present there are 2 federal agencies that sponsor 42 federally funded research and development centers (FFRDCs).

The article discusses the origin of the federally funded research and development centers (FFRDCs).

An appendix is presented, which includes chart showing number of federally funded research and development centers from fiscal year 1967-2017.

The article discusses the background of federally funded research and development centers (FFRDCs).